Related Experiment Video
Updated: Feb 20, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Managing Epstein-Barr virus and other risk factors in MS-Future perspectives
1Department of Pharmacology and Clinical Neuroscience, Section of Neurology, Umeå University, Umeå, Sweden.
Abstract:
Here, we discuss the rationale and feasibility of treatment directed against the modifiable risk factors in multiple sclerosis. The established environmental risk factors vitamin D insufficiency, cigarette smoke exposure, adolescence overweight, and Epstein-Barr virus infection are reviewed. Already available measures to target these risk factors are discussed.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Microorganisms in Medicine and Therapeutics
EPS and iPS Cells in Disease Research
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Rheumatic Heart Disease III: Medical Management

